The Perfect Summary Podcast

Neuroscientist Christof Koch explains what consciousness is, how to measure it, and how VR, meditation and psychedelics can widen our view of reality.

Harvard's Paola Arlotta explains how the brain develops, what brain organoids can and cannot show, and the ethics of growing them.

Bret Contreras explains how often to lift, how to keep progressing without injury, how to grow glutes and how to bring up lagging muscles.

Dr. Amy Shah explains 30/30/3: 30 grams of protein at your first meal, 30 grams of fiber a day and three probiotic foods daily.

Dr. David Fajgenbaum explains how approved drugs can treat other diseases, and how one saved his own life after five near-fatal relapses.

Neuroscientist Poppy Crum explains how technology reshapes the brain, how to use AI to learn instead of offloading, and what digital twins can do.

Andrew Huberman explains the brain's threat reflex and why undoing fear means detailed re-exposure followed by a new, positive association.

Stanford ear surgeon Konstantina Stankovic explains how hearing works, what damages it, how to protect it, and why hearing loss matters for the brain.

Skiing champion Mikaela Shiffrin explains why thinking about winning makes her lose, and how she learned to race through anxiety.

Neuroscientist David Berson tours the brain from retina to cortex: color vision, the body clock, balance, motion sickness and plasticity.

Andrew Huberman explains how the lymphatic system clears fluid and waste, and how movement, breathing, side sleeping and cardio keep it flowing.

Yann LeCun explains why deep learning works, why human intelligence is not general, and why self-supervised world models are the next step for AI.

Mel Robbins shares five small steps, from a brain dump to claiming one win, for getting back on track within a day.

Neuroscientist Tommy Wood on why the brain needs challenge, how much dementia is preventable, and what Formula One teaches about performance.

Duke neuroscientist Jennifer Groh explains how we locate sound, why eardrums move with the eyes, what a thought may be, and how she focuses.

Stanford lecturer Matt Abrahams shares drills and frameworks for clear, confident speaking, from stage fright to small talk.

Andrew Huberman explains the brain's social homeostasis circuit, why loneliness drives us to connect, and how shared experience builds bonds.

Dermatologist Dr. Shereene Idriss on the three-step routine, what to skip, actives, adult acne, sunscreen and why jowls are structural.

Neuroscientist Glen Jeffery on how red and infrared light support mitochondria, vision and blood sugar, and why he worries about LED lighting.

Elon Musk on testing consciousness, regulating AI, Neuralink's brain interface, Autopilot's progress and Carl Sagan's Pale Blue Dot.

Andrew Huberman on dopamine, visual focus, visualizing failure and a short space-time bridging exercise for pursuing goals.

Columbia's Martin Picard explains mitochondria as energy transformers and why stress, sleep, food and purpose shape energy and aging.

Psychologist Rachel Goldman tells Mel Robbins how a pause, regular meals and kinder thoughts can ease emotional eating and body shame.

Neuroscientist Wendy Suzuki explains what anxiety is for and shares tools, from joy conditioning to exercise, for putting it to use.

A compilation of seven guests on manifestation, from the law of attraction to a neuroscientist's version built on attention, habits and work.

Cancer neurosurgeon Rahul Jandial shares his playbook for crisis, the daily breathing ritual he relies on, and what dying patients wish they had done.

Mel Robbins explains her one-day plan for clearing overdue tasks: a brain dump, then blocks for calls, errands, money, email and rescheduling.

Michael Pollan on the unsolved mystery of consciousness, plant awareness, chatbots that crowd out our inner lives, and the gut-brain link.

Psychologist Mariel Buqué explains how she believes trauma passes through families and the daily practices she uses to calm the nervous system.

Rick Perry and Bryan Hubbard report that Texas will fund $100 million of ibogaine drug trials, and make their case for the compound.